DOXORUBICIN 14-VALERATE
UNII VX84V04LL9

Substance Identification & Data

This profile provides standardized clinical and technical data for Doxorubicin 14-valerate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VX84V04LL9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 80287-44-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
VX84V04LL9
CAS Registry Number
80287-44-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DOXORUBICIN 14-VALERATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C32H37NO12
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
HPIIJTZSULGOAB-IIOUFYMLSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
10349017
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c12c(C(=O)c3c(C1=O)cccc3OC)c(O)c4c(c2O)C[C@](C(=O)COC(CCCC)=O)(O)C[C@@H]4O[C@@]5(O[C@@H](C)[C@H]([C@H](C5)N)O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Doxorubicin 14-valerate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

ADRIAMYCIN 14-VALERATE
DOXORUBICIN 14-VALERATE
VALRUBICIN IMPURITY, DOXORUBICIN VALERATE [USP IMPURITY]

Systematic Nomenclature

2-((2S,4S)-4-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-1,2,3,4,6,11-HEXAHYDROTETRACEN-2-YL)-2-OXOETHYL PENTANOATE
PENTANOIC ACID, 2-((2S,4S)-4-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-1,2,3,4,6,11-HEXAHYDRO-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-2-NAPHTHACENYL)-2-OXOETHYL ESTER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound